BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38027217)

  • 1. Renal complications in chronic hypoparathyroidism - a systematic cross-sectional assessment.
    Gronemeyer K; Fuss CT; Hermes F; Plass A; Koschker AC; Hannemann A; Völzke H; Hahner S
    Front Endocrinol (Lausanne); 2023; 14():1244647. PubMed ID: 38027217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
    Laurer E; Grünberger J; Naidoo U; Lanzersdorfer R; Wimleitner M; Tischlinger K; Högler W
    Bone; 2021 Mar; 144():115834. PubMed ID: 33359892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of hypercalciuria and renal calcifications in chronic hypoparathyroidism: A cross-sectional study.
    Ridder LO; Harsløf T; Sikjaer T; Underbjerg L; Rejnmark L
    Clin Endocrinol (Oxf); 2021 Aug; 95(2):286-294. PubMed ID: 33756016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrocalcinosis, Renal Dysfunction, and Calculi in Patients With Primary Hypoparathyroidism on Long-Term Conventional Therapy.
    Saha S; Kandasamy D; Sharma R; Bal C; Sreenivas V; Goswami R
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31901096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Renal Function and Calcifications in Primary Hyperparathyroidism: A Nested Case-Control Study.
    Ejlsmark-Svensson H; Bislev LS; Rolighed L; Sikjaer T; Rejnmark L
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3574-3583. PubMed ID: 29955845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications.
    Lopes MP; Kliemann BS; Bini IB; Kulchetscki R; Borsani V; Savi L; Borba VZ; Moreira CA
    Arch Endocrinol Metab; 2016; 60(6):532-536. PubMed ID: 27901178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variables.
    Starup-Linde J; Waldhauer E; Rolighed L; Mosekilde L; Vestergaard P
    Eur J Endocrinol; 2012 Jun; 166(6):1093-100. PubMed ID: 22474170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment.
    Marcucci G; Beccuti G; Carosi G; Cetani F; Cianferotti L; Colao AM; Di Somma C; Duradoni M; Elefante A; Ghizzoni L; Giusti M; Lania AG; Lavezzi E; Madeo B; Mantovani G; Marcocci C; Masi L; Parri S; Pigliaru F; Santonati A; Spada A; Vera L; Brandi ML
    J Endocrinol Invest; 2022 Sep; 45(9):1653-1662. PubMed ID: 35460461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Hypoparathyroidism Treatment on the Kidney in Children: Long-Term Retrospective Follow-Up Study.
    Levy I; Licht C; Daneman A; Sochett E; Harrington J
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4106-13. PubMed ID: 26323021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teriparatide (rhPTH 1-34) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism.
    Tuli G; Buganza R; Tessaris D; Einaudi S; Matarazzo P; de Sanctis L
    Endocrine; 2020 Feb; 67(2):457-465. PubMed ID: 31705387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials.
    Puliani G; Hasenmajer V; Simonelli I; Sada V; Pofi R; Minnetti M; Cozzolino A; Napoli N; Pasqualetti P; Gianfrilli D; Isidori AM
    J Bone Miner Res; 2022 Jul; 37(7):1233-1250. PubMed ID: 35485213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
    Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
    Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 1,25-Dihydroxyvitamin D as a Biomarker of the Absence of Hypercalciuria in Postsurgical Hypoparathyroidism.
    García-Pascual L; Barahona MJ; Perea V; Simó R
    J Clin Endocrinol Metab; 2017 Jan; 102(1):259-266. PubMed ID: 27813709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
    Winer KK; Kelly A; Johns A; Zhang B; Dowdy K; Kim L; Reynolds JC; Albert PS; Cutler GB
    J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Russian Registry of Chronic Hypoparathyroidism.
    Kovaleva EV; Eremkina AK; Elfimova AR; Krupinova JA; Bibik EE; Maganeva IS; Gorbacheva AM; Dobreva EA; Melnichenko GA; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():800119. PubMed ID: 35250859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study.
    Ayodele O; Rejnmark L; Mu F; Lax A; Berman R; Swallow E; Gosmanova EO
    Adv Ther; 2022 Nov; 39(11):5013-5024. PubMed ID: 36018496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Nephrolithiasis and Nephrocalcinosis in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study.
    Ketteler M; Chen K; Gosmanova EO; Signorovitch J; Mu F; Young JA; Sherry N; Rejnmark L
    Adv Ther; 2021 Apr; 38(4):1946-1957. PubMed ID: 33704680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review : Renal disease in chronic hypoparathyroidism.
    Gosmanova EO; Houillier P; Rejnmark L; Marelli C; Bilezikian JP
    Rev Endocr Metab Disord; 2021 Jun; 22(2):297-316. PubMed ID: 33599907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with PTH 1-34 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27 years at a single tertiary care center.
    Winer KK; Ye S; Ferré EMN; Schmitt MM; Zhang B; Cutler GB; Lionakis MS
    Bone; 2021 Aug; 149():115977. PubMed ID: 33932619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.